🎯 check Ponatinib (AP24534) product page
Ponatinib (AP24534) is a potent, ATP-competitive multi-kinase (BCR-ABL, FGFR, PDGFR) inhibitor. It affects PI3K/AKT, MAPK/ERK, and STAT signaling pathways by binding to the kinase ATP-binding site, effectively inhibiting tumor cell proliferation and inducing apoptosis.